LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Department of Justice Recovers More Than $2.2 Billion in 2020
Legal & Regulatory and Reimbursement

Department of Justice Recovers More Than $2.2 Billion in 2020

February 8, 2021 2 min read Premium comments

Advertisement

Department of Justice Recovers More Than $2.2 Billion in 2020
Courtesy of Wikimedia Commons and Tracey O; Pixabay and Nikolay Frolochkin
Secondary#spinefrontier#departmentofjustice#oklahomecenterfororthopaedicandmultispecialtysurgery

The Department of Justice (DOJ) closed its 2020 fiscal year by recovering more than $2.2 billion from fraud and false claims settlements and judgments.

The DOJ announced the amounts were for the past fiscal year ending September 30, 2020. Over $1.8 billion of the more than $2.2 billion “relates to matters that involved the health care industry, including drug and medical device manufacturers, managed care providers, hospitals, pharmacies, hospice organizations, laboratories, and physicians.”

During the past year, the DOJ made significant recoveries for kickback schemes. These schemes involved the “the willful solicitation or payment of illegal remuneration to induce the purchase of a good or service paid for by a federal health care program.”

Of note in the orthopedic industry was the DOJ’s settlement with the Oklahoma Center for Orthopaedic and Multi-Specialty Surgery and associated entities for more than $72 million. The settlement resolved allegations involving improper remuneration. For OTW’s coverage of this settlement, see “$72.3 Million Settles DOJ Vs Ortho Clinic Case.”

Another significant orthopedic case involves SpineFrontier, Inc., SpineFrontier CEO Kingsley Chin, and additional related entities. The government has alleged that the parties paid kickbacks to surgeons in the form of sham “consulting” fees to “induce use of SpineFrontier surgical devices.” In connection with the litigation, six orthopedic surgeons have agreed to pay over $3.25 million to resolve kickback allegations. For OTW’s continued coverage of the SpineFrontier kickback allegations, see “Surgeon Pays $1.75 Million To Settle Kickback Allegations” and “U.S. Attorney Sues SpineFrontier Over Alleged Kickback Scheme.”

Whistleblowers had a lucrative year with over half of the $2.2 billion in settlements and judgments coming from whistleblower (qui tam) lawsuits. The DOJ announced that from its 2020 recovery amount “over $1.6 billion arose from lawsuits filed under the qui tam provisions of the False Claims Act.” If the government succeeds in a qui tam action, the whistleblower can receive a portion of the recovery. During fiscal year 2020, the DOJ paid $309 million to the individuals who filed whistleblower lawsuits.

The number of whistleblower lawsuits has increased over the years. In fiscal year 2020, whistleblowers filed 672 qui tam suits. For OTW’s 2020 coverage of actions involving whistleblowers and fraud allegations, see “Florida Orthopedic Surgeon Continues Litigation,” “Fort Worth Orthopedist Indicted for Healthcare Fraud,” “Former Life Spine Employees’ Suit Alleges Retaliatory Discharge,” “Orthopedic Surgeon Gives Whistleblowing a Shot,” and “Agnesian Healthcare Pays $10 Million To Settle Whistleblower Case.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy